Monday, August 1, 2022
9:00 - 9:10 AM

Welcome and Introduction 

9:10 - 9:40 AM

The current state of diabetes in the US and globally
A. Enrique Caballero, MD

9:40 - 10:05 AM

Current approach to eye disease diagnosis and management 
Paolo Silva, MD

10:05 - 10:25 AM

Clinical case and Q&A session

10:25 - 10:40 AM

Mid-morning break

10:40 - 11:05 AM

Addressing sexual dysfunction in both men and women with diabetes
Martin N. Kathrins, MD
* NOT RECORDED

11:05 - 11:25 AM

Clinical case and Q&A session 

11:25 - 11:30 AM

Break

11:30 - 11:55 AM

Update on the diagnosis and management of diabetic neuropathy 
James Russell

11:55 AM - 12:15 PM

Clinical Case and Q&A session
Enrique Caballero + TBD 

12:15 - 1:15 PM

Lunch Break

1:15 - 1:40 PM

Peripheral vascular disease in patients with diabetes
Allen D. Hamdan, MD

1:40 - 2:00 PM

Clinical case and Q&A session 

2:00 - 2:05 PM

Transition Break

2:05 - 2:30 PM

Key lessons during this pandemic
Nadine Palermo, MD

2:30 - 2:50 PM

Q&A session

2:50 - 3:10 PM

Break-out session: Key teaching points of the day

3:10 - 3:35 PM

Full group debrief

Tuesday, August 2, 2022
9:00 - 9:05 AM

Welcome

9:05 - 9:30 AM

The causes and implications of hypoglycemia 
Devin Steenkamp, MBChB

9:30 - 9:55 AM

Educating our patients on hypoglycemia prevention and management
Charles McKitrick, RN, CDCES

9:55 - 10:20 AM

Clinical case and Q&A session 

10:20 - 10:35 AM

Break

10:35 - 11:00 AM

The clinical impact of obesity
Osama Hamdy, MD

11:00 - 11:25 AM

Obesity, diabetes and cancer
Jennifer A. Ligibel, MD

11:25 - 11:50 AM

Panel discussion and Q&A

11:50 AM - 12:50 PM

Lunch Break

12:50 - 1:15 PM

Lifestyle Modification
Kellene Isom

1:15 - 1:40 PM

Medical Management
Scott Butsch, MD MSc FTOS

1:40 - 1:45 PM

Transition Break

1:45 - 2:10 PM

Surgical Management
Caroline Apovian, MD

2:10 - 2:40 PM

Clinical Cases and Q&A

2:40 - 3:00 PM

Break-out session: Key teaching points of the day

3:00 - 3:25 PM

Full group debrief

Wednesday, August 3, 2022
9:00 - 9:05 AM

Welcome

9:05 - 9:30 AM

NASH - An update 
Ken Cusi, MD

9:30 - 9:50 AM

Clinical case and Q&A session

9:50 - 9:55 AM

Break

9:55 - 10:20 AM

Hypertension management in 2022
Naomi Fisher, MD

10:20 - 10:45 AM

Dyslipidemia management update
Om Ganda, MD

10:45 - 11:00 AM

Break

11:00 - 11:25 AM

Clinical case and Q&A session

11:25 AM - 12:15 PM

Comprehensive management of diabetes: Old and new approaches
 Antonio Ceriello

12:15 - 1:15 PM

Lunch break

1:15 - 1:40 PM

Heart failure in the patient with diabetes: Practical implications
Deepak Bhatt, MD

1:40 - 2:05 PM

Coronary artery disease: Diagnosis and management
Chris Cannon, MD

2:05 - 2:10 PM

Break

2:10 - 2:40 PM

Clinical case and Q&A session

2:40 - 3:00 PM

Break-out session: Key teaching points of the day

3:00 - 3:25 PM

Full group debrief

Thursday, August 4, 2022
9:00 - 9:05 AM

Welcome

9:05 - 9:30 AM

Chronic kidney disease in diabetes 
Robert Stanton, MD

9:30 - 9:50 AM

Clinical case and Q&A session

9:50 - 9:55 AM

Break

9:55 - 10:20 AM

The role of biguanides and sulfonylureas 
Enrique Caballero, MD

10:20 - 10:40 AM

Is there still a role for TZDs?
Bindu Chamarti, MD, MMSc

10:40 - 10:55 AM

Break

10:55 - 11:20 AM

Insulin use in the setting of chronic complications
Guillermo Umpierrez, MD 

11:20 AM - 12:00 PM

Clinical case discussions and Q&A session

12:00 - 1:00 PM

Lunch break

1:00 - 1:25 PM

Incretin-based therapies: DPP-IV inhibitors and GLP-1 RA
Lee-Shing Chang, MD

1:25 - 1:50 PM

SGLT-2 inhibitors
Mandeep Bajaj, MBBS

1:50 - 1:55 PM

Break

1:55 - 2:30 PM

Clinical cases and Q&A session

2:30 - 2:35 PM

Break

2:35 - 3:00 PM

Break-out session: Key teaching points of the day

3:00 - 3:25 PM

Full group debrief

3:25 - 3:35 PM

Closing remarks